Protein tyrosine kinase enzyme inhibitors

Details Protein tyrosine kinase enzyme inhibitors Protein tyrosine kinase enzyme inhibitors

2008-07-15

2008-07-15

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S153000, C546S152000

Reexamination Certificate

active

07399865

ABSTRACT:
This invention provides compounds of formula 1, having the structurewherein R1, R2, R3, R4, and R5are described within the specification.

REFERENCES:
patent: 6288082 (2001-09-01), Wissner et al.
patent: 6288802 (2001-09-01), Hoshina et al.
patent: 6821988 (2004-11-01), Wissner et al.
patent: WO 98/43960 (1998-10-01), None
patent: WO 2000/018761 (2000-04-01), None
patent: WO 03/050090 (2003-06-01), None
patent: WO 2004/096224 (2004-11-01), None
Kin, CA 136:308014 abstract only of Oncology Reports, VOI 9(1), pp. 3-9, 2002.
Hung, CA 132:135559, abstract only of seminars in Oncology, vol. 25(4, Suppl. 12), pp. 51-59, 1999.
Plosker, Drugs, vol. 66(4), pp. 449-475, 2006.
UPESLACIS, Janis, Oct. 16, 2002, meeting at McGill University, Canada, Evolution of Kinase Inhibitors at Wyeth.
Rabindran, S. K., et al.; Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase; Cancer Research 64:3958-3965; Jun. 1, 2004.

Affiliated with

Also associated with

Rating

Protein tyrosine kinase enzyme inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein tyrosine kinase enzyme inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein tyrosine kinase enzyme inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2784909